You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it. In addition as per local health authority Regulations, some of our products are not approved for sales, marketing or distribution in all countries.
NEWS / EVENTS / .........

EVENTS - 19-02-2008

European GMP, current issues and future developments: Kedrion in the organising committee of the EMA / PDA Joint Conference

Kedrion (Italy) is the only company working in the plasma derivatives industry which is sitting on the organising committee of the EMEA/PDA (Parenteral Drug Association) Joint Conference. The company appointed Claudia Nardini, in charge of Industrial Development and Research for the company and deputy president of the Italian chapter of the PDA, as its delegate; she will also chair the “Dedicated Facilities” session of the Conference.

The meeting, due to take place in Budapest, Hungary, on February 20th and 21st, will review the state of the art and potential developments of the “European GMP”, through a confrontation with the regulatory authorities and the industry.

Taking inspiration from the past experience of its US counterpart (PDA/FDA Joint conference), the European Conference seems also be following its fast accreditation process with the opinion leaders, as it has actually grown from about 180 members in 2007, the year of the first conference, to about 400 this year

For more information please contact: